A popular supplement used to treat joint problems is linked to an increase in developing diabetes as a new study shows.

The study shows the high levels of glucosamine found in the supplement can kill cells found in the pancreas which produces insulin, thus increase ones chance of developing diabetes where the malfunction of these cells is linked with the development of the condition.

Frederic Picard led the study and published the findings in Journal of Endocrinology, the team studies in-vitro cell in rats and mice. They then exposed the cells to high doses of glucosamine which is 10 times higher than the daily recommendation of 1,500 milligrams.

The results showed the dosage triggered mechanisms which lowers high blood sugar levels and also destroyed a protein with is vital for cell survival called SIRT1, by an estimated 50% which leads to death of the cells.
They will have an impact on how older people deal with arthritis and problems associated with joins, believing that higher doses of gluco will help ease their conditions.

Picard however said glucosamine was not harmful to humans in general; however, higher doses may have adverse effects.

In Canada sale of the supplement have risen in the past few years. In 2009 the value of gluco by hospitals and drug stores was $14.6 million, while in 2008 the figure was $7.6 million.
Glucosamine is combined with chondroitin sulphate to reduce joint pain.

National Institutes of Health investigation showed that the element did not perform any better than a placebo.
Bookman, of the Canadian Arthritis Society, said the supplement did not help patients in any way, yet patients still initiated on using it along with other remedies.

Image Credit: